Aeterna Zentaris to Present at Two Upcoming Investment Conferences in the United States

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUÉBEC CITY, Sept. 1, 2011 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that its President and\n CEO, Juergen Engel, Ph.D., will make corporate presentations at the\n following investment conferences:\n\n\nWednesday, September 7, 2011\nStifel Nicolaus 2011 Healthcare Conference2:05 p.m. (Eastern Time)\nPhillips Room, Four Seasons Hotel, Boston\n\n\nTuesday, September 13, 2011\nRodman Renshaw Annual Global Investment Conference10:25 a.m. (Eastern Time)\nStarlight Center, Waldorf-Astoria Hotel, New York\n\n\nA live webcast of the presentations will be available on Aeterna\n Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be\n available on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris Inc.\n\n\nAeterna Zentaris is a late-stage oncology drug development company\n currently investigating potential treatments for various cancers\n including colorectal, multiple myeloma, endometrial, ovarian, prostate\n and bladder cancer. The Company's innovative approach of \"personalized\n medicine\" means tailoring treatments to a patient's specific condition\n and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn\n from its proprietary discovery unit providing the Company with constant\n and long-term access to state-of-the-art therapeutic options. For more\n information please visit www.aezsinc.com.\n\n\n","length":1661,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.